AI assistant
Sending…
Marker Therapeutics, Inc. — Director's Dealing 2016
Nov 30, 2016
35150_dirs_2016-11-30_8148176b-4f1d-4d0b-aec6-1e1ba57b53a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TAPIMMUNE INC (TPIV)
CIK: 0001094038
Period of Report: 2016-11-28
Reporting Person: Silverman Joshua (Director)
More from Marker Therapeutics, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Annual Report
2026
Mar 18
Regulatory Filings
2026
Feb 9
Director's Dealing
2025
Nov 19
Director's Dealing
2025
Nov 19
Director's Dealing
2025
Nov 19
Major Shareholding Notification
2025
Nov 17